title: Erratum to: A Phase 1 dose-escalation study of the safety and pharmacokinetics of once-daily oral foretinib, a multi-kinase inhibitor, in patients with solid tumors.
authors.affiliation: Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
authors.forename: Geoffrey I
authors.initials: GI
authors.lastname: Shapiro
authors.affiliation: GlaxoSmithKline, Collegeville, PA, USA.
authors.forename: Stewart
authors.initials: S
authors.lastname: McCallum
authors.affiliation: Medimmune, Gaithersburg, MD, USA. adamsla@medimmune.com.|Oncology Research and Development, GlaxoSmithKline, Research Triangle Park, Durham, NC, USA. adamsla@medimmune.com.
authors.forename: Laurel M
authors.initials: LM
authors.lastname: Adams
authors.affiliation: Janssen Research & Development, Spring House, PA, USA.|GlaxoSmithKline, Collegeville, PA, USA.
authors.forename: Laurie
authors.initials: L
authors.lastname: Sherman
authors.affiliation: Oncology Research and Development, GlaxoSmithKline, Research Triangle Park, Durham, NC, USA.
authors.forename: Steve
authors.initials: S
authors.lastname: Weller
authors.affiliation: CSL Behring, King of Prussia, PA, USA.|GlaxoSmithKline, Collegeville, PA, USA.
authors.forename: Suzanne
authors.initials: S
authors.lastname: Swann
authors.affiliation: Astex Pharmaceuticals, Inc., Pleasanton, CA, USA.|Exelixis, South San Francisco, CA, USA.
authors.forename: Harold
authors.initials: H
authors.lastname: Keer
authors.affiliation: Exelixis, South San Francisco, CA, USA.|Genentech, San Francisco, CA, USA.
authors.forename: Dale
authors.initials: D
authors.lastname: Miles
authors.affiliation: Exelixis, South San Francisco, CA, USA.|Biomarker, Translational & Predictive Medicine Consulting, San Francisco, CA, USA.
authors.forename: Thomas
authors.initials: T
authors.lastname: Müller
authors.affiliation: University of Chicago, Chicago, IL, USA.|Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Collegeville, PA, USA.
authors.forename: Daniel C
authors.initials: DC
authors.lastname: Rabe
authors.affiliation: NantOmics, LLC, Rockville, MD, USA.|Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Collegeville, PA, USA.
authors.forename: Fabiola
authors.initials: F
authors.lastname: Cecchi
authors.affiliation: Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
authors.forename: Donald P
authors.initials: DP
authors.lastname: Bottaro
authors.affiliation: Yale Cancer Center, New Haven, CT, USA.|Barbara Ann Karmanos Cancer Institute/Wayne State University, Detroit, MI, USA.
authors.forename: Patricia
authors.initials: P
authors.lastname: LoRusso